Patents by Inventor Rosa Gobbi

Rosa Gobbi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10098927
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: October 16, 2018
    Assignee: INNOMED S.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Publication number: 20170087213
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Patent number: 9555084
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: January 31, 2017
    Assignee: INNOMED S.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Patent number: 9492512
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Grant
    Filed: December 27, 2012
    Date of Patent: November 15, 2016
    Assignee: INNOMED S.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Patent number: 9248151
    Abstract: The present invention relates to topical vaginal compositions in gel form containing immune mediators, growth factors, chemotactic factors and antibacterial/antiviral factors extracted from bovine colostrum, and optionally other ingredients with complementary activity.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: February 2, 2016
    Assignee: ZAMBON S.P.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Publication number: 20150010497
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Application
    Filed: December 27, 2012
    Publication date: January 8, 2015
    Applicant: BIONEST LTD.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Publication number: 20140369957
    Abstract: The present invention refers to a combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3a/C4a, immunoglobulins and chemotactic factors. The invention also relates to a process for the preparation of said combination from serum, placenta or colostrum and to composition containing said combination for use in the treatment of conditions requiring tissue repair and regeneration and for the substitution of stem cell therapies.
    Type: Application
    Filed: December 27, 2012
    Publication date: December 18, 2014
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Publication number: 20140322329
    Abstract: The present invention relates to topical vaginal compositions in gel form containing immune mediators, growth factors, chemotactic factors and antibacterial/antiviral factors extracted from bovine colostrum, and optionally other ingredients with complementary activity.
    Type: Application
    Filed: December 2, 2011
    Publication date: October 30, 2014
    Applicant: ZAMBON S.P.A.
    Inventors: Alberto Bartorelli, Maria Rosa Gobbi
  • Patent number: 7705051
    Abstract: The use of calcium trifluoroacetate for the preparation of a drug for the treatment of plasma cell neoplasias, particularly multiple myeloma.
    Type: Grant
    Filed: September 20, 2005
    Date of Patent: April 27, 2010
    Assignee: Eureon AG
    Inventor: Rosa Gobbi
  • Publication number: 20090203939
    Abstract: The use of calcium trifluoroacetate for the preparation of a drug for the treatment of plasma cell neoplasias, particularly multiple myeloma.
    Type: Application
    Filed: September 20, 2005
    Publication date: August 13, 2009
    Applicant: Bion-Est Ltd.
    Inventor: Rosa Gobbi
  • Publication number: 20070260088
    Abstract: Calcium trifluoroacetate, known to have cytotoxic activity, is endowed With of antiangiogenetic activity and can be used for the therapy of atherosclerotic plaque, rheumatoid arthritis, psoriasis, diabetic retinopathy, rosacea, cheloids, metastasis.
    Type: Application
    Filed: June 17, 2005
    Publication date: November 8, 2007
    Inventor: Rosa Gobbi